Physician profile
Peter J Scott
NPI 1588638480
$527.35
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $40.07 · 2020: $24.67 · 2021: $27.39 · 2022: $12.38 · 2023: $355 · 2024: $67.95.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $423.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $422.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Telix Pharmaceuticals | $226.46 | 2023 | Illuccix |
| Merck Sharp & Dohme LLC | $95.95 | 2019-2024 | Vaxelis, Gardasil 9, Vaxneuvance |
| Glaxosmithkline, LLC. | $46.65 | 2021-2024 | Bexsero, Rotarix |
| Kaleo, INC. | $44.60 | 2023-2024 | Auvi-Q |
| Pfizer INC. | $41.01 | 2023-2024 | |
| Cranial Technologies, INC | $19.53 | 2023 | Doc Band |
| Genentech USA, INC. | $15.00 | 2019 | |
| Sobi, INC | $13.48 | 2019 | |
| Ironshore Pharmaceuticals INC. | $12.38 | 2020 | |
| Dermira, INC. | $12.29 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Scott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.